British Columbia Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.97M Sell
30,632
-9,325
-23% -$3.06M 0.05% 259
2025
Q4
$14M Sell
39,957
-38,515
-49% -$13M 0.07% 210
2025
Q3
$25.4M Buy
78,472
+42,847
+120% +$13.3M 0.15% 130
2025
Q2
$13.9M Sell
35,625
-8,728
-20% -$3.51M 0.08% 191
2025
Q1
$19.3M Sell
44,353
-53
-0.1% -$21.3K 0.12% 160
2024
Q4
$16.4M Buy
44,406
+5,624
+15% +$2.35M 0.1% 182
2024
Q3
$20.2M Sell
38,782
-5,785
-13% -$3.09M 0.12% 139
2024
Q2
$24.1M Buy
44,567
+16,420
+58% +$8.68M 0.15% 128
2024
Q1
$14.6M Buy
28,147
+1,020
+4% +$507K 0.1% 148
2023
Q4
$12.8M Buy
27,127
+5,574
+26% +$2.58M 0.1% 151
2023
Q3
$9.38M Buy
21,553
+108
+0.5% +$49K 0.09% 161
2023
Q2
$9.53M Buy
21,445
+84
+0.4% +$38.8K 0.09% 170
2023
Q1
$9.82M Buy
21,361
+63
+0.3% +$30K 0.1% 172
2022
Q4
$10.9M Sell
21,298
-2,552
-11% -$1.3M 0.12% 156
2022
Q3
$10.8M Sell
23,850
-4,175
-15% -$2M 0.12% 149
2022
Q2
$13.5M Sell
28,025
-9,491
-25% -$4.7M 0.13% 135
2022
Q1
$18.4M Sell
37,516
-5,350
-12% -$2.45M 0.12% 136
2021
Q4
$19.9M Sell
42,866
-2,397
-5% -$1.01M 0.11% 159
2021
Q3
$16.9M Sell
45,263
-77
-0.2% -$29.3K 0.1% 175
2021
Q2
$17.3M Buy
45,340
+4,482
+11% +$1.71M 0.11% 173
2021
Q1
$14.7M Sell
40,858
-1,716
-4% -$552K 0.11% 183
2020
Q4
$13.7M Sell
42,574
-1,204
-3% -$369K 0.1% 186
2020
Q3
$11.8M Buy
43,778
+3,343
+8% +$900K 0.1% 180
2020
Q2
$10.6M Buy
40,435
+12,663
+46% +$3.38M 0.11% 177
2020
Q1
$6.3M Sell
27,772
-32,593
-54% -$8.88M 0.11% 167
2019
Q4
$18.2M Buy
60,365
+22,212
+58% +$6.11M 0.14% 134
2019
Q3
$9.16M Sell
38,153
-16,409
-30% -$4.5M 0.09% 248
2019
Q2
$15.4M Buy
54,562
+662
+1% +$181K 0.13% 154
2019
Q1
$15.5M Sell
53,900
-22,536
-29% -$6.52M 0.14% 155
2018
Q4
$20.1M Buy
76,436
+10,394
+16% +$2.86M 0.18% 127
2018
Q3
$18.1M Sell
66,042
-49,864
-43% -$12.9M 0.19% 117
2018
Q2
$27.6M Sell
115,906
-53,154
-31% -$12.3M 0.24% 98
2018
Q1
$37.1M Sell
169,060
-24,975
-13% -$5.87M 0.28% 77
2017
Q4
$43.7M Buy
194,035
+3,802
+2% +$810K 0.31% 72
2017
Q3
$36.1M Buy
190,233
+34,483
+22% +$6.56M 0.28% 80
2017
Q2
$29.3M Sell
155,750
-636
-0.4% -$114K 0.23% 103
2017
Q1
$25.9M Sell
156,386
-20,059
-11% -$3.19M 0.21% 117
2016
Q4
$25.4M Buy
176,445
+14,561
+9% +$1.95M 0.22% 104
2016
Q3
$20.3M Sell
161,884
-11,384
-7% -$1.47M 0.2% 114
2016
Q2
$22.8M Sell
173,268
-3,325
-2% -$455K 0.2% 112
2016
Q1
$24.5M Buy
176,593
+4,472
+3% +$598K 0.23% 102
2015
Q4
$24M Sell
172,121
-14,123
-8% -$1.95M 0.23% 101
2015
Q3
$26.1M Buy
186,244
+4,547
+3% +$683K 0.27% 91
2015
Q2
$29.8M Buy
181,697
+46,435
+34% +$7.42M 0.28% 86
2015
Q1
$20.9M Sell
135,262
-44,968
-25% -$6.4M 0.19% 139
2014
Q4
$22.6M Buy
180,230
+27,791
+18% +$3.43M 0.19% 139
2014
Q3
$18.2M Sell
152,439
-35,838
-19% -$4.11M 0.15% 171
2014
Q2
$20.3M Sell
188,277
-84
-0% -$8.65K 0.16% 161
2014
Q1
$18.8M Sell
188,361
-86,839
-32% -$7.85M 0.16% 161
2013
Q4
$25.4M Buy
275,200
+33,380
+14% +$2.97M 0.2% 130
2013
Q3
$20.2M Sell
241,820
-34,698
-13% -$2.97M 0.17% 145
2013
Q2
$22.6M Buy
+276,518
New +$20.7M 0.19% 124

Other funds holding ELV

British Columbia Investment Management's ELV Position: Q1 2026 in Review

British Columbia Investment Management reduced its Elevance Health (ELV) stake by 23% in Q1 2026, selling an estimated $3.06M and leaving 30,632 shares worth $8.97M. The position accounts for 0.05% of the portfolio, ranked #259.

British Columbia Investment Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $43.7M in Q4 2017. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • British Columbia Investment Management held 30,632 shares of Elevance Health worth $8.97M as of Q1 2026.
  • British Columbia Investment Management sold 9,325 Elevance Health shares in Q1 2026, an estimated $3.06M.
  • Elevance Health made up 0.05% of British Columbia Investment Management's portfolio in Q1 2026, its #259 holding.
  • British Columbia Investment Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • British Columbia Investment Management's Elevance Health position peaked at $43.7M in Q4 2017.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.